
Afatin 20mg Tablet
Marketer
BDR Pharmaceuticals Internationals Pvt
Salt Composition
Afatinib dimaleate (20mg)
Overview Afatin 20mg Tablet
Afatin 20mg tablets are indicated for treating non-small cell lung cancer in adults with specific epidermal growth factor receptor (EGFR) gene mutations. Optimal absorption requires administration on an empty stomach, consistently at the same time daily. Dosage and frequency are determined by your physician, based on your individual needs and may be adjusted. Strictly adhere to your prescribed regimen; incorrect usage or overdose can lead to severe adverse events. Therapeutic benefits may not be apparent immediately; continue treatment as directed unless instructed otherwise by your doctor. Common side effects include nausea, rash, dry skin, and diarrhea, the latter potentially requiring medical management and hydration. Regular blood tests may be recommended. Photosensitivity is possible; utilize sunscreen and protective clothing during sun exposure. Report any ocular discomfort, such as dryness, pain, or redness. Prior to commencing treatment, disclose any respiratory issues, hepatic or renal impairment, and current medications, especially anti-infectives. Potential drug interactions exist; fully inform your healthcare provider of all medications you are taking. This medication is contraindicated during pregnancy and lactation; women of childbearing age should employ effective contraception throughout treatment.
Primary Ingredients of Afatin 20mg Tablet
No text provided to rephrase.
Uses of Afatin 20mg Tablet
Lung cancer (excluding small cell types)
Major Benefits of Afatin 20mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 20mg Afatin tablet whole; avoid chewing, crushing, or breaking it. Administer this medication on an empty stomach.
Common Side effects of Afatin 20mg Tablet:
- Diarrhea
- Rash
- Dry skin
- Nausea
- Vomiting
- Loss of appetite
- Itching
- Stomatitis (Inflammation of the mouth)
- Nail disorder
How to use Afatin 20mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 20mg Afatin tablet whole; avoid chewing, crushing, or fracturing it. Administer on an empty stomach.
How Afatin 20mg Tablet works:
Afatin 20mg tablets are an anti-neoplastic agent. Their mechanism involves targeted inhibition of enzyme receptors—EGFR, HER2, and HER4—crucial for cancer cell proliferation. This blockage disrupts signaling pathways, thereby suppressing or retarding tumor growth and metastasis.
SAFETY ADVICE
AlcoholSAFE
Afatin 20mg Tablet can be taken with alcohol without adverse reactions.
PregnancyCONSULT YOUR DOCTOR
Use of Afatin 20mg tablets during pregnancy is contraindicated due to established risk to the fetus. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingCONSULT YOUR DOCTOR
Use of Afatin 20mg tablets while breastfeeding is likely unsafe. Preliminary evidence in humans indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCONSULT YOUR DOCTOR
Afatin 20mg Tablet's impact on driving ability is undetermined. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Afatin 20mg tablets are likely safe for individuals with kidney impairment. Current evidence indicates dose modification may be unnecessary, but physician consultation is recommended.
LiverSAFE IF PRESCRIBED
Afatin 20mg tablets are likely safe for individuals with hepatic impairment. Current evidence indicates dose modification may be unnecessary, however, physician consultation is recommended.
What if you forget to take Afatin 20mg Tablet :
Omit any missed Afatin 20mg Tablet dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Afatin 20mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Butenamide-Quinazoline Hybrid |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Actions | Kinase inhibitors targeting tyrosine |
